$RBOT
Vicarious Surgical Inc. Stock $rbot

$rbot Overview Financials Valuation SEC Filings Company Website

2022 Q4 Form 10-K Financial Statement

#000121390023011661 Filed on February 15, 2023

Income Statement

Concept	2022 Q4	2022	2021
Revenue	$0.00	$0.00	$0.00
YoY Change
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin	$8.733M	$36.18M	$16.16M
YoY Change	2.06%	123.93%	406.62%
% of Gross Profit
Research & Development	$11.88M	$43.90M	$22.06M
YoY Change	28.33%	99.01%	125.18%
% of Gross Profit
Depreciation & Amortization	$402.0K	$1.111M	$316.0K
YoY Change	219.05%	251.58%	101.27%
% of Gross Profit
Operating Expenses	$20.61M	$80.08M	$38.22M
YoY Change	15.71%	109.55%	194.3%
Operating Profit		-$80.08M	-$38.22M
YoY Change		109.5%
Interest Expense	$721.0K	$200.0K	-$69.00K
YoY Change	-6654.55%	-389.86%	-162.73%
% of Operating Profit
Other Income/Expense, Net	$8.709M	$84.00M	$3.085M
YoY Change	-78.02%	2622.85%
Pretax Income	-$11.18M	$5.157M	-$35.21M
YoY Change	-151.32%	-114.65%	173.45%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$11.18M	$5.157M	-$35.21M
YoY Change	-151.32%	-114.65%	173.45%
Net Earnings / Revenue
Basic Earnings Per Share		$0.04	-$0.36
Diluted Earnings Per Share	-$0.09	$0.04	-$294.0K
COMMON SHARES
Basic Shares Outstanding		121.8M shares	96.69M shares
Diluted Shares Outstanding		127.5M shares	96.69M shares

Balance Sheet

Concept	2022 Q4	2022	2021
SHORT-TERM ASSETS
Cash & Short-Term Investments	$116.2M	$116.2M	$173.5M
YoY Change	-33.02%	-33.02%	928.68%
Cash & Equivalents	$116.2M	$116.2M	$173.5M
Short-Term Investments
Other Short-Term Assets	$4.196M	$4.196M	$4.867M
YoY Change	-13.79%	-13.79%	1786.43%
Inventory
Prepaid Expenses	$4.196M
Receivables
Other Receivables
Total Short-Term Assets	$120.4M	$120.4M	$178.4M
YoY Change	-32.5%	-32.5%	941.6%
LONG-TERM ASSETS
Property, Plant & Equipment	$6.586M	$18.86M	$2.250M
YoY Change	192.71%	738.18%	405.62%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$92.00K	$1.028M	$1.055M
YoY Change	-91.28%	-2.56%	383.94%
Total Long-Term Assets	$19.89M	$19.89M	$3.305M
YoY Change	501.72%	501.72%	398.49%
TOTAL ASSETS
Total Short-Term Assets	$120.4M	$120.4M	$178.4M
Total Long-Term Assets	$19.89M	$19.89M	$3.305M
Total Assets	$140.3M	$140.3M	$181.7M
YoY Change	-22.78%	-22.78%	921.36%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.731M	$1.731M	$1.500M
YoY Change	15.4%	15.4%	302.14%
Accrued Expenses	$5.808M	$6.646M	$4.098M
YoY Change	41.73%	62.18%	940.1%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due	$16.00K	$16.00K	$647.0K
YoY Change	-97.53%	-97.53%	1276.6%
Total Short-Term Liabilities	$8.393M	$8.393M	$6.245M
YoY Change	34.4%	34.4%	667.2%
LONG-TERM LIABILITIES
Long-Term Debt		$0.00	$691.0K
YoY Change		-100.0%	996.83%
Other Long-Term Liabilities	$20.85M	$20.85M	$91.65M
YoY Change	-77.25%	-77.25%	157920.69%
Total Long-Term Liabilities	$0.00	$20.85M	$92.34M
YoY Change	-100.0%	-77.42%	76216.53%
TOTAL LIABILITIES
Total Short-Term Liabilities	$8.393M	$8.393M	$6.245M
Total Long-Term Liabilities	$0.00	$20.85M	$92.34M
Total Liabilities	$29.25M	$29.25M	$98.59M
YoY Change	-70.34%	-70.34%	10444.17%
SHAREHOLDERS EQUITY
Retained Earnings	-$61.64M
YoY Change	-7.72%
Common Stock	$11.00K
YoY Change	10.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$6.021M
YoY Change	-93.31%
Treasury Stock Shares	27.65M shares
Shareholders Equity	$111.0M	$111.0M	$83.09M
YoY Change
Total Liabilities & Shareholders Equity	$140.3M	$140.3M	$181.7M
YoY Change	-22.78%	-22.78%	921.36%

Cashflow Statement

Concept	2022 Q4	2022	2021
OPERATING ACTIVITIES
Net Income	-$11.18M	$5.157M	-$35.21M
YoY Change	-151.32%	-114.65%	173.45%
Depreciation, Depletion And Amortization	$402.0K	$1.111M	$316.0K
YoY Change	219.05%	251.58%	101.27%
Cash From Operating Activities	-$18.41M	-$61.21M	-$33.30M
YoY Change	88.75%	83.83%	176.61%
INVESTING ACTIVITIES
Capital Expenditures	$992.0K	$5.352M	-$1.289M
YoY Change	-214.42%	-515.21%	974.17%
Acquisitions		$1.200M
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$992.0K	-$5.352M	-$1.289M
YoY Change	14.42%	315.21%	-109.76%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	8.812M	$9.145M	192.2M
YoY Change	-1913.17%	-95.24%	1321.86%
NET CHANGE
Cash From Operating Activities	-18.41M	-$61.21M	-33.30M
Cash From Investing Activities	-992.0K	-$5.352M	-1.289M
Cash From Financing Activities	8.812M	$9.145M	192.2M
Net Change In Cash	-10.59M	-$57.42M	157.6M
YoY Change	-4.66%	-136.44%	973.34%
FREE CASH FLOW
Cash From Operating Activities	-$18.41M	-$61.21M	-$33.30M
Capital Expenditures	$992.0K	$5.352M	-$1.289M
Free Cash Flow	-$19.40M	-$66.56M	-$32.01M
YoY Change	118.33%	107.95%	168.58%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2022	dei	Document Type DocumentType	10-K
CY2022	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2022	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2022
CY2022	dei	Document Annual Report DocumentAnnualReport	true
CY2022	dei	Document Period End Date DocumentPeriodEndDate	2022-12-31
CY2022	dei	Document Transition Report DocumentTransitionReport	false
CY2022	dei	Entity File Number EntityFileNumber	001-39384
CY2022	dei	Entity Registrant Name EntityRegistrantName	VICARIOUS SURGICAL INC.
CY2022	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2022	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	87-2678169
CY2022	dei	Entity Address Address Line1 EntityAddressAddressLine1	78 Fourth Avenue
CY2022	dei	Entity Address City Or Town EntityAddressCityOrTown	Waltham
CY2022	dei	Entity Address State Or Province EntityAddressStateOrProvince	MA
CY2022	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	02451
CY2022	dei	City Area Code CityAreaCode	(617)
CY2022	dei	Local Phone Number LocalPhoneNumber	868-1700
CY2022	dei	Security12b Title Security12bTitle	Class A common stock, $0.0001 par value per share
CY2022	dei	Trading Symbol TradingSymbol	RBOT
CY2022	dei	Security Exchange Name SecurityExchangeName	NYSE
CY2022	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	No
CY2022	dei	Entity Voluntary Filers EntityVoluntaryFilers	Yes
CY2022	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2022	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2022	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
CY2022	dei	Entity Small Business EntitySmallBusiness	true
CY2022	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	true
CY2022	dei	Entity Ex Transition Period EntityExTransitionPeriod	false
CY2022	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	false
CY2022	dei	Entity Shell Company EntityShellCompany	false
CY2022Q2	dei	Entity Public Float EntityPublicFloat	299600000	usd
CY2022	dei	Auditor Firm AuditorFirmId	34
CY2022	dei	Auditor Name AuditorName	Deloitte & Touche LLP
CY2022	dei	Auditor Location AuditorLocation	Boston, Massachusetts
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	116208000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	173507000	usd
CY2022Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4196000	usd
CY2021Q4	us-gaap	Prepaid Expense Current PrepaidExpenseCurrent	4867000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	120404000	usd
CY2021Q4	us-gaap	Assets Current AssetsCurrent	178374000	usd
CY2022Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	936000	usd
CY2021Q4	us-gaap	Restricted Cash Noncurrent RestrictedCashNoncurrent	1055000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6586000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2250000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	12273000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	92000	usd
CY2022Q4	us-gaap	Assets Assets	140291000	usd
CY2021Q4	us-gaap	Assets Assets	181679000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1731000	usd
CY2021Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1500000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	5808000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	838000	usd
CY2022Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	16000	usd
CY2021Q4	us-gaap	Capital Lease Obligations Current CapitalLeaseObligationsCurrent	47000	usd
CY2021Q4	rbot	Current Portion Of Term Loan CurrentPortionOfTermLoan	600000	usd
CY2021Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	4098000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8393000	usd
CY2021Q4	us-gaap	Liabilities Current LiabilitiesCurrent	6245000	usd
CY2022Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	14832000	usd
CY2021Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent	1631000	usd
CY2021Q4	rbot	Notes Payable Equipment Loans Of Net Current NotesPayableEquipmentLoansOfNetCurrent	16000	usd
CY2021Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	675000	usd
CY2022Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	6021000	usd
CY2021Q4	us-gaap	Warrants And Rights Outstanding WarrantsAndRightsOutstanding	90021000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	29246000	usd
CY2021Q4	us-gaap	Liabilities Liabilities	98588000	usd
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2021Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2021Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	11000	usd
CY2021Q4	us-gaap	Common Stock Value CommonStockValue	10000	usd
CY2022Q4	rbot	Common Stock Value One CommonStockValueOne	2000	usd
CY2021Q4	rbot	Common Stock Value One CommonStockValueOne	2000	usd
CY2022Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	172673000	usd
CY2021Q4	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	149877000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-61641000	usd
CY2021Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-66798000	usd
CY2022Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	111045000	usd
CY2021Q4	us-gaap	Stockholders Equity Including Portion Attributable To Noncontrolling Interest StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest	83091000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	140291000	usd
CY2021Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	181679000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	43900000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	22059000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	6463000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	2961000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	29715000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	13203000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	80078000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	38223000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	-80078000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	-38223000	usd
CY2022	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-84000000	usd
CY2021	us-gaap	Fair Value Adjustment Of Warrants FairValueAdjustmentOfWarrants	-3085000	usd
CY2022	us-gaap	Investment Income Interest InvestmentIncomeInterest	1435000	usd
CY2021	us-gaap	Investment Income Interest InvestmentIncomeInterest	20000	usd
CY2022	us-gaap	Interest Expense InterestExpense	200000	usd
CY2021	us-gaap	Interest Expense InterestExpense	89000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	5157000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-35207000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5157000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-35207000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	-29817000	usd
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	0.04
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.36
CY2021	us-gaap	Stock Issued During Period Value Other StockIssuedDuringPeriodValueOther	46670000	usd
CY2021	us-gaap	Stock Repurchased And Retired During Period Value StockRepurchasedAndRetiredDuringPeriodValue	16853000	usd
CY2021	us-gaap	Stock Issued During Period Value Issued For Services StockIssuedDuringPeriodValueIssuedForServices	97314000	usd
CY2021	rbot	Exercise Of Common Stock Options ExerciseOfCommonStockOptions	421000	usd
CY2021	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants	16000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	-35207000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	83091000	usd
CY2022	rbot	Exercise Of Common Stock Options ExerciseOfCommonStockOptions	842000	usd
CY2022	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	12255000	usd
CY2022	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	9700000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	5157000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	111045000	usd
CY2022	us-gaap	Profit Loss ProfitLoss	5157000	usd
CY2021	us-gaap	Profit Loss ProfitLoss	-35207000	usd
CY2022	us-gaap	Depreciation Depreciation	1111000	usd
CY2021	us-gaap	Depreciation Depreciation	316000	usd
CY2021	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1	-8000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	12255000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	3694000	usd
CY2022	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	75000	usd
CY2021	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	21000	usd
CY2022	us-gaap	Other Noncash Expense OtherNoncashExpense	829000	usd
CY2022	rbot	Change In Fair Values Of Warrant Liabilities ChangeInFairValuesOfWarrantLiabilities	-84000000	usd
CY2021	rbot	Change In Fair Values Of Warrant Liabilities ChangeInFairValuesOfWarrantLiabilities	-3085000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	-671000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Expense IncreaseDecreaseInPrepaidExpense	4609000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	135000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	1127000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	1711000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	3704000	usd
CY2022	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability	937000	usd
CY2021	rbot	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent	733000	usd
CY2022	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets	92000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-61211000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-33298000	usd
CY2022	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	5352000	usd
CY2021	us-gaap	Payments To Acquire Other Property Plant And Equipment PaymentsToAcquireOtherPropertyPlantAndEquipment	1289000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-5352000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1289000	usd
CY2022	us-gaap	Repayments Of Construction Loans Payable RepaymentsOfConstructionLoansPayable	47000	usd
CY2021	us-gaap	Repayments Of Construction Loans Payable RepaymentsOfConstructionLoansPayable	47000	usd
CY2022	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts	10000000	usd
CY2022	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering	-300000	usd
CY2021	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt	1500000	usd
CY2022	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	1350000	usd
CY2021	us-gaap	Repayments Of Bank Debt RepaymentsOfBankDebt	150000	usd
CY2021	rbot	Proceeds From Reverse Recapitalization Net Of Issuance Costs ProceedsFromReverseRecapitalizationNetOfIssuanceCosts	190424000	usd
CY2021	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants	16000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	842000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	421000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	174562000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	9145000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	192164000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-57418000	usd
CY2022Q4	rbot	Cash And Cash Equivalents Restricted CashAndCashEquivalentsRestricted	116208000	usd
CY2021Q4	rbot	Cash And Cash Equivalents Restricted CashAndCashEquivalentsRestricted	173507000	usd
CY2022Q4	us-gaap	Restricted Cash RestrictedCash	936000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	157577000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	174562000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	16985000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	117144000	usd
CY2021Q4	us-gaap	Restricted Cash RestrictedCash	1055000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	117144000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	174562000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	41000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	36000	usd
CY2022	rbot	Leasehold Improvements Acquired In Connection With Waltham Lease LeaseholdImprovementsAcquiredInConnectionWithWalthamLease	1200000	usd
CY2021	rbot	Leasehold Improvements Acquired In Connection With Waltham Lease LeaseholdImprovementsAcquiredInConnectionWithWalthamLease	840000	usd
CY2021	rbot	Warrants Assumed In Acquisition WarrantsAssumedInAcquisition	93110000	usd
CY2022	rbot	Accruals For Property Plant And Equipment Purchased During The Period AccrualsForPropertyPlantAndEquipmentPurchasedDuringThePeriod	95000	usd
CY2022	us-gaap	Use Of Estimates UseOfEstimates	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b>Use of Estimates</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The preparation of financial statements in conformity with US GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods presented. Estimates are used for, but are not limited to, the Company’s ability to continue as a going concern, depreciation of property and equipment, fair value of financial instruments, and contingencies. Actual results may differ from those estimates.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in">The accompanying consolidated financial statements have been prepared assuming that the Company will continue as a going concern. Management has evaluated whether there are conditions and events that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date the financial statements are issued.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p>
CY2022	rbot	Cash Balance CashBalance	936000	usd
CY2021	rbot	Cash Balance CashBalance	1055000	usd
CY2022	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-align: justify"><b>Concentrations of Credit Risk and Off-Balance-Sheet Risk</b></p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"> </p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0; text-indent: 0.25in"><span>The Company has no significant off-balance-sheet risk, such as foreign exchange contracts, option contracts, or other foreign hedging arrangements. Financial instruments that potentially expose the Company to concentrations of credit risk consist mainly of cash and cash equivalents. The Company maintains its cash and cash equivalents principally with accredited financial institutions of high-credit standing</span>.</p><p style="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0"><b><i> </i></b></p>
CY2022Q4	us-gaap	Class Of Warrant Or Right Number Of Securities Called By Warrants Or Rights ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights	10400000	shares
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	24000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	16000	usd
CY2021	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	8000	usd
CY2022	rbot	Total Shares Of Common Stock Immediately After Business Combination TotalSharesOfCommonStockImmediatelyAfterBusinessCombination	118622312	shares
CY2022	rbot	Debt Instrument Convertible Conversion Shares DebtInstrumentConvertibleConversionShares	3.29831
CY2022Q4	us-gaap	Debt Instrument Interest Rate Effective Percentage DebtInstrumentInterestRateEffectivePercentage	0.50	pure
CY2022	rbot	Increased Number Of Shares Authorized Of Captial Stock IncreasedNumberOfSharesAuthorizedOfCaptialStock	143931076	shares
CY2022	rbot	Aggregate Shares Of Common Stock AggregateSharesOfCommonStock	14200000	shares
CY2022	rbot	Value Of Aggregate Purchaseprice Common Stock ValueOfAggregatePurchasepriceCommonStock	142000000	usd
CY2021	rbot	Cash Trust And Cash Net Of Redemptions CashTrustAndCashNetOfRedemptions	77993000	usd
CY2021	rbot	Cash Pipe Financing CashPIPEFinancing	142000000	usd
CY2021	rbot	Transaction Costs And Advisory Fees TransactionCostsAndAdvisoryFees	29569000	usd
CY2021	rbot	Net Proceeds From Reverse Recapitalization NetProceedsFromReverseRecapitalization	190424000	usd
CY2021Q4	rbot	Less Warrant Liabilities Assumed LessWarrantLiabilitiesAssumed	-93110000	usd
CY2021	rbot	Net Assets And Liabilities Assumed In Reverse Recapitalization NetAssetsAndLiabilitiesAssumedInReverseRecapitalization	97314000	usd
CY2022	rbot	Common Stock Outstanding Prior To The Business Combinationin Dollars CommonStockOutstandingPriorToTheBusinessCombinationinDollars	34500000	shares
CY2022	us-gaap	Temporary Equity Accretion To Redemption Value Adjustment TemporaryEquityAccretionToRedemptionValueAdjustment	-26745028000	usd
CY2022	rbot	D8 Public Shares D8PublicShares	7754972	shares
CY2022	rbot	D8 Sponsor Shares D8SponsorShares	8625000	shares
CY2022	rbot	Shares Issued In Pipe Financing SharesIssuedInPIPEFinancing	14200000	shares
CY2022	rbot	Business Combination And Pipe Financing Shares BusinessCombinationAndPIPEFinancingShares	30579972	shares
CY2022	rbot	Legacy Vicarious Surgical Shares LegacyVicariousSurgicalShares	88042340	shares
CY2022Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	114409000	usd
CY2022Q4	us-gaap	Other Assets OtherAssets	114409000	usd
CY2022Q4	rbot	Total Property And Equipment Gross1 TotalPropertyAndEquipmentGross1	8281000	usd
CY2021Q4	rbot	Total Property And Equipment Gross1 TotalPropertyAndEquipmentGross1	2834000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	1695000	usd
CY2021Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	584000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	6586000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	2250000	usd
CY2022Q3	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1200000	usd
CY2022Q4	us-gaap	Leasehold Improvements Gross LeaseholdImprovementsGross	1200000	usd
CY2021Q2	us-gaap	Land Improvements LandImprovements	840000	usd
CY2022Q4	us-gaap	Land Improvements LandImprovements	840000	usd
CY2021	us-gaap	Gain Loss On Termination Of Lease GainLossOnTerminationOfLease	24000	usd
CY2021Q4	us-gaap	Property Plant And Equipment Other Accumulated Depreciation PropertyPlantAndEquipmentOtherAccumulatedDepreciation	16000	usd
CY2021	us-gaap	Equity Method Investment Realized Gain Loss On Disposal EquityMethodInvestmentRealizedGainLossOnDisposal	8000	usd
CY2022	us-gaap	Accumulated Depreciation Depletion And Amortization Reclassifications From Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationReclassificationsFromPropertyPlantAndEquipment1	1111000	usd
CY2021	us-gaap	Accumulated Depreciation Depletion And Amortization Reclassifications From Property Plant And Equipment1 AccumulatedDepreciationDepletionAndAmortizationReclassificationsFromPropertyPlantAndEquipment1	316000	usd
CY2022Q4	us-gaap	Other Liabilities OtherLiabilities	6021000	usd
CY2021Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	171196000	usd
CY2021Q4	us-gaap	Other Assets OtherAssets	171196000	usd
CY2021Q4	us-gaap	Other Liabilities OtherLiabilities	90021000	usd
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.72	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.60	pure
CY2022Q4	us-gaap	Share Price SharePrice	2.02
CY2021Q4	us-gaap	Share Price SharePrice	10.62
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P3Y8M12D
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P4Y8M12D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.041	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.012	pure
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2021Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	27648621	shares
CY2021Q4	us-gaap	Treasury Stock Value TreasuryStockValue	90021000	usd
CY2022	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	20	shares
CY2022	rbot	Change In Value Value ChangeInValueValue	-84000000	usd
CY2022Q4	us-gaap	Treasury Stock Shares TreasuryStockShares	27648601	shares
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	6021000	usd
CY2022Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5240000	usd
CY2021Q4	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	3233000	usd
CY2022Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	568000	usd
CY2021Q4	us-gaap	Accrued Professional Fees Current And Noncurrent AccruedProfessionalFeesCurrentAndNoncurrent	865000	usd
CY2022	rbot	Accrued Expenses AccruedExpenses	5808000	usd
CY2021	rbot	Accrued Expenses AccruedExpenses	4098000	usd
CY2020Q4	us-gaap	Short Term Borrowings ShortTermBorrowings	3500000	usd
CY2022	us-gaap	Certain Loans And Debt Securities Acquired In Transfer Description Of How Prepayments Are Considered In Determination Of Contractual Cash Flows And Cash Flows Expected To Be Collected CertainLoansAndDebtSecuritiesAcquiredInTransferDescriptionOfHowPrepaymentsAreConsideredInDeterminationOfContractualCashFlowsAndCashFlowsExpectedToBeCollected	The loan consisted of up to two tranches; a $1,500 tranche which became available to the Company upon the close of the loan agreement in October 2020 and was available to the Company to draw through March 31, 2021 and a second tranche of $2,000 which became available to the Company through September 30, 2021, upon the Company’s successful achievement of a milestone related to the development of the Company’s surgical robot. Although the milestone was achieved, the Company chose not to draw down the $2,000 tranche.
CY2022	us-gaap	Debt Instrument Maturity Date Description DebtInstrumentMaturityDateDescription	The term loan was interest-only through September 30, 2021, at which time the Company made the first of 30 equal monthly payments of principal plus interest. The term loan bears interest at a floating rate equal to the Prime Rate, but not less than a minimum rate of 3.25%. In addition, the final payment made at the earlier of the maturity of the loan or its termination included a deferred interest payment of 7.5% of the amount borrowed, resulting in a minimum annual rate of 5.98% to be paid to the lender. The term loan had prepayment fees if the Company elected to repay such loan prior to it becoming due, which penalties varied based upon the time remaining before the term loan was due. If the Company had repaid the term loan prior to the first anniversary of the term loan closing, it would have been required to pay a prepayment fee of 3% of the outstanding principal balance.
CY2021Q1	us-gaap	Short Term Borrowings ShortTermBorrowings	1500000	usd
CY2022	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	0	usd
CY2021	us-gaap	Shortterm Debt Average Outstanding Amount ShorttermDebtAverageOutstandingAmount	1350000	usd
CY2022	rbot	Prepayment Fee Percentage PrepaymentFeePercentage	0.02	pure
CY2022	rbot	Incurred Expenses IncurredExpenses	100000	usd
CY2022	us-gaap	Interest Expense Debt InterestExpenseDebt	75000	usd
CY2021	us-gaap	Interest Expense Debt InterestExpenseDebt	25000	usd
CY2022	rbot	Fair Value Of Common Stock Warrant Per Shares FairValueOfCommonStockWarrantPerShares	0.33
CY2022	rbot	Total Financing Cost TotalFinancingCost	85000	usd
CY2022	rbot	Excercise Of Warrant ExcerciseOfWarrant	146577	shares
CY2022	rbot	Equipment Loans Description EquipmentLoansDescription	The equipment loans had an aggregate principal balance of $185 at inception, with forty-eight equal monthly payments of principal and interest due beginning ninety days after taking possession of the machinery. The equipment loans are collateralized by the underlying machinery. As of December 31, 2022 and 2021, the aggregate outstanding principal balance of the equipment loans was $0 and $16, respectively, net of current portions of $16 and $47, respectively.
CY2022	us-gaap	Interest Expense Other InterestExpenseOther	1000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	17000	usd
CY2022Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	17000	usd
CY2022Q1	rbot	Lease Asset LeaseAsset	14302000	usd
CY2022Q1	us-gaap	Lease Deposit Liability LeaseDepositLiability	15933000	usd
CY2022	us-gaap	Direct Operating Costs DirectOperatingCosts	2210000	usd
CY2021	us-gaap	Direct Operating Costs DirectOperatingCosts	1447000	usd
CY2022	us-gaap	Operating Lease Cost OperatingLeaseCost	2210000	usd
CY2021	us-gaap	Operating Lease Cost OperatingLeaseCost	1447000	usd
CY2022	us-gaap	Lease Cost LeaseCost	2210000	usd
CY2021	us-gaap	Lease Cost LeaseCost	1447000	usd
CY2022	us-gaap	Operating Lease Lease Income Lease Payments OperatingLeaseLeaseIncomeLeasePayments	1644000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	1200000	usd
CY2022	us-gaap	Operating Lease Payments OperatingLeasePayments	444000	usd
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P9Y3M18D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0874	pure
CY2022Q4	rbot	Operating Lease Future Minimum Payments Due In Two Year OperatingLeaseFutureMinimumPaymentsDueInTwoYear	2162000	usd
CY2022Q4	rbot	Operating Lease Future Minimum Payments Due In Three Year OperatingLeaseFutureMinimumPaymentsDueInThreeYear	2286000	usd
CY2022Q4	rbot	Operating Lease Future Minimum Payments Due In Four Year OperatingLeaseFutureMinimumPaymentsDueInFourYear	2358000	usd
CY2022Q4	rbot	Operating Lease Future Minimum Payments Due In Five Years OperatingLeaseFutureMinimumPaymentsDueInFiveYears	2430000	usd
CY2022Q4	rbot	Operating Lease Future Minimum Payments Due In Six Year OperatingLeaseFutureMinimumPaymentsDueInSixYear	2502000	usd
CY2022Q4	rbot	Operating Leases Future Minimum Payments Due Thereafter Value OperatingLeasesFutureMinimumPaymentsDueThereafterValue	11430000	usd
CY2022Q4	rbot	Operating Lease Future Minimum Payments Due OperatingLeaseFutureMinimumPaymentsDue	23168000	usd
CY2022Q4	rbot	Interest Amount InterestAmount	7498000	usd
CY2022Q4	rbot	Carrying Value Of Lease Liabilities CarryingValueOfLeaseLiabilities	15670000	usd
CY2022	us-gaap	Payments For Rent PaymentsForRent	9700000	usd
CY2022	rbot	Settle Payment SettlePayment	118000	usd
CY2021	us-gaap	Other Selling General And Administrative Expense OtherSellingGeneralAndAdministrativeExpense	118000	usd
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.21	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	1.26	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation State And Local Income Taxes EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes	-0.08	pure
CY2022	rbot	Effective Income Tax Rate Reconciliation Tax Credits Permanent Differences EffectiveIncomeTaxRateReconciliationTaxCreditsPermanentDifferences	0.01	pure
CY2021	rbot	Effective Income Tax Rate Reconciliation Tax Credits Permanent Differences EffectiveIncomeTaxRateReconciliationTaxCreditsPermanentDifferences	0	pure
CY2022	rbot	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants	3.42	pure
CY2021	rbot	Effective Income Tax Rate Reconciliation Change In Fair Value Of Warrants EffectiveIncomeTaxRateReconciliationChangeInFairValueOfWarrants	-0.02	pure
CY2022	rbot	Effective Income Tax Rate Reconciliation Return To Provision EffectiveIncomeTaxRateReconciliationReturnToProvision	0.28	pure
CY2022	rbot	Effective Income Tax Rate Reconciliation Officers Compensation EffectiveIncomeTaxRateReconciliationOfficersCompensation	0.02	pure
CY2021	rbot	Effective Income Tax Rate Reconciliation Transaction Costs EffectiveIncomeTaxRateReconciliationTransactionCosts	0.05	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	0.06	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Share Based Compensation Excess Tax Benefit Percent EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent	-0.01	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	0.52	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Tax Credits EffectiveIncomeTaxRateReconciliationTaxCredits	-0.04	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	5.18	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance	-0.39	pure
CY2022	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2021	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	27688000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	18269000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	7057000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards DeferredTaxAssetsTaxCreditCarryforwards	2727000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	1303000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost	657000	usd
CY2022Q4	rbot	Deferred Tax Assets Tax Deferred Expense Capitalized Rd Expenses DeferredTaxAssetsTaxDeferredExpenseCapitalizedRDExpenses	11456000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	1953000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals Reserves DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves	1065000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	61000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Other DeferredTaxAssetsOther	56000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	49518000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	22774000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	49518000	usd
CY2021Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	22774000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	26700000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	13800000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards Foreign DeferredTaxAssetsOperatingLossCarryforwardsForeign	2800000	usd
CY2022Q4	rbot	Deferred Tax Operating Loss Unlimited Carryforwards DeferredTaxOperatingLossUnlimitedCarryforwards	100000000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards State And Local DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal	96600000	usd
CY2022Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	4300000	usd
CY2021Q4	us-gaap	Deferred Tax Assets In Process Research And Development DeferredTaxAssetsInProcessResearchAndDevelopment	3500000	usd
CY2022Q4	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	1000000	shares
CY2022Q4	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.0001
CY2022Q4	rbot	Preferred Stock Share Authorized PreferredStockShareAuthorized	71152084	shares
CY2022Q4	rbot	Preferred Stock Share Issued PreferredStockShareIssued	66550928	shares
CY2022Q4	rbot	Preferred Stock Share Issued PreferredStockShareIssued	66550928	shares
CY2022Q4	rbot	Preferred Stock Values PreferredStockValues	46670000	usd
CY2022	rbot	Restricted Stock Agreement Description RestrictedStockAgreementDescription	In 2014, the Company issued 19,789,860 shares of Legacy Class A common stock to the initial founders of the Company at par that contained a repurchase right by the Company at the lesser of the original purchase price of $0.0001 per share or the then current fair value of the share, which lapsed over a four-year period. In 2016 and 2018, these shares were amended with respect to the lapse of the repurchase rights, such that beginning as of January 2018 60% percent of the shares were vested and the remaining shares vest over a thirty-six month period.
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Award Vesting Period1 ShareBasedCompensationArrangementByShareBasedPaymentAwardAwardVestingPeriod1	P4Y
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	698051	shares
CY2020Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	12.54
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod	3266548	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	3.89
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod	769269	shares
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue	6.62
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeited In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeitedInPeriod	110207	shares
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Forfeitures Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsForfeituresWeightedAverageGrantDateFairValue	8.2
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber	3085123	shares
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue	5.01
CY2022	rbot	Weighted Average Period weightedAveragePeriod	P2Y10M24D
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation Forfeited StockIssuedDuringPeriodValueShareBasedCompensationForfeited	8400	usd
CY2021	rbot	Weighted Average Period weightedAveragePeriod	P3Y3M18D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	6598	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	2901000	usd
CY2021Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Exercisable Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestExercisableAggregateIntrinsicValue	6407	usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Nonvested SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueNonvested	480000	usd
CY2022Q4	rbot	Aggregate Intrinsic Value Of Rsu AggregateIntrinsicValueOfRSU	6232000	usd
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	96690716	shares
CY2020Q3	rbot	Additional Shares AdditionalShares	900000	shares
CY2022Q4	rbot	Private Placement Warrants Outstanding PrivatePlacementWarrantsOutstanding	10400000	shares
CY2022	rbot	Exercisable Price Per Share ExercisablePricePerShare	11.5
CY2022	rbot	Warrant Description WarrantDescription	Redemption of Warrants when the price per share of Class A common stock equals or exceeds $18.00. The Company may call the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.01 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption; and ● if, and only if, the last reported sale price of Class A common stock equals or exceeds $18.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders. Redemption of Warrants when the price per share of Class A common stock equals or exceeds $10.00. The Company may call the Public Warrants for redemption: ● in whole and not in part; ● at a price of $0.10 per warrant; ● upon a minimum of 30 days’ prior written notice of redemption; provided that holders will be able to exercise their warrants on a cashless basis prior to redemption and receive that number of shares based on the redemption date and the “fair market value” of the Company’s Class A common stock; and ● if, and only if, the last reported sale price of Class A common stock shares equals or exceeds $10.00 per share (as adjusted) for any 20 trading days within a 30-trading day period ending three trading days before the Company sends the notice of redemption to the warrant holders. The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in D8’s initial public offering, except that the Private Placement Warrants and the shares of Class A common stock issuable upon exercise of the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) are not redeemable by the Company, (ii) could not (including the shares of Class A common stock issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) are entitled to registration rights.
CY2022	rbot	Granted Options To Purchase GrantedOptionsToPurchase	5576191	shares
CY2021	rbot	Granted Options To Purchase GrantedOptionsToPurchase	5870433	shares
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	15461000	usd
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1	21271000	usd
CY2022	us-gaap	Stock Option Plan Expense StockOptionPlanExpense	25427000	usd
CY2022	rbot	Sharebased Compensation Arrangement By Sharebased Payment Award Nonvestweighted Average Period Expected Term SharebasedCompensationArrangementBySharebasedPaymentAwardNonvestweightedAveragePeriodExpectedTerm	P3Y3D
CY2022	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	2696000	usd
CY2021	us-gaap	Other Research And Development Expense OtherResearchAndDevelopmentExpense	975000	usd
CY2022	rbot	Sales And Marketing Expense SalesAndMarketingExpense	1296000	usd
CY2021	rbot	Sales And Marketing Expense SalesAndMarketingExpense	621000	usd
CY2022	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	8263000	usd
CY2021	us-gaap	Other General And Administrative Expense OtherGeneralAndAdministrativeExpense	2098000	usd
CY2022	rbot	Share Based Compensations ShareBasedCompensations	12255000	usd
CY2021	rbot	Share Based Compensations ShareBasedCompensations	3694000	usd
CY2021Q4	rbot	Share Based Compensation Arrangement By Share Based Payment Award Options ShareBasedCompensationArrangementByShareBasedPaymentAwardOptions	12009768	shares
CY2021Q4	rbot	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Per Share ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePricePerShare	2.92
CY2022	rbot	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm	P7Y9M3D
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5576191	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.34
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Exercised ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsExercised	2291868	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	0.36
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	1101674	shares
CY2022	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	2.89
CY2022Q4	rbot	Share Based Compensation Arrangement By Share Based Payment Award Options ShareBasedCompensationArrangementByShareBasedPaymentAwardOptions	14192417	shares
CY2022Q4	rbot	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Exercise Price Per Share ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingExercisePricePerShare	3.9
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P8Y3M3D
CY2022	rbot	Weighted Average Fair Values Of Options Granted WeightedAverageFairValuesOfOptionsGranted	2.77
CY2021	rbot	Weighted Average Fair Values Of Options Granted WeightedAverageFairValuesOfOptionsGranted	3.62
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	10066000	usd
CY2021Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	13010000	usd
CY2022Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Equity Instruments Other Than Options Aggregate Intrinsic Value Outstanding SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueOutstanding	6804000	usd
CY2022Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	48391	shares
CY2021Q4	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	44863	shares
CY2022	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	802000	usd
CY2021	us-gaap	Stock Issued During Period Value Employee Benefit Plan StockIssuedDuringPeriodValueEmployeeBenefitPlan	424000	usd
CY2022	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	5157000	usd
CY2021	us-gaap	Net Income Loss Available To Common Stockholders Basic NetIncomeLossAvailableToCommonStockholdersBasic	-35207000	usd
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	121791878	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	127528509	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	96690716	shares
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	35604874	shares
CY2023Q1	us-gaap	Participating Policies As Percentage Of Gross Insurance In Force ParticipatingPoliciesAsPercentageOfGrossInsuranceInForce	0.14	pure
CY2023Q1	us-gaap	Subsequent Event Effect Of Change In Tax Status SubsequentEventEffectOfChangeInTaxStatus	1000000	usd
CY2021Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset		usd
CY2021Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent		usd
CY2021Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent		usd
CY2022Q4	rbot	Current Portion Of Term Loan CurrentPortionOfTermLoan		usd
CY2021Q4	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent		usd
CY2022Q4	us-gaap	Deferred Rent Credit Noncurrent DeferredRentCreditNoncurrent		usd
CY2022Q4	rbot	Notes Payable Equipment Loans Of Net Current NotesPayableEquipmentLoansOfNetCurrent		usd
CY2022Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2021Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue		usd
CY2021Q4	us-gaap	Convertible Preferred Stock Nonredeemable Or Redeemable Issuer Option Value ConvertiblePreferredStockNonredeemableOrRedeemableIssuerOptionValue		usd
CY2022Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2021Q4	us-gaap	Preferred Stock Value PreferredStockValue		usd
CY2022Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2021Q4	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued		shares
CY2022Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2021Q4	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding		shares
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	0.04
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.36
CY2021	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised		usd
CY2021	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	3694000	usd
CY2021	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		usd
CY2022	us-gaap	Stock And Warrants Issued During Period Value Preferred Stock And Warrants StockAndWarrantsIssuedDuringPeriodValuePreferredStockAndWarrants		usd
CY2022	us-gaap	Stock Issued During Period Value Restricted Stock Award Forfeitures StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures		usd
CY2022	us-gaap	Gain Loss On Disposition Of Assets1 GainLossOnDispositionOfAssets1		usd
CY2021	us-gaap	Other Noncash Expense OtherNoncashExpense		usd
CY2021	us-gaap	Increase Decrease In Operating Lease Liability IncreaseDecreaseInOperatingLeaseLiability		usd
CY2022	rbot	Increase Decrease In Deferred Rent IncreaseDecreaseInDeferredRent		usd
CY2021	us-gaap	Increase Decrease In Other Noncurrent Assets IncreaseDecreaseInOtherNoncurrentAssets		usd
CY2021	us-gaap	Proceeds From Debt Net Of Issuance Costs ProceedsFromDebtNetOfIssuanceCosts		usd
CY2021	us-gaap	Proceeds From Issuance Initial Public Offering ProceedsFromIssuanceInitialPublicOffering		usd
CY2022	us-gaap	Proceeds From Bank Debt ProceedsFromBankDebt		usd
CY2022	rbot	Exercised Value ExercisedValue		usd
CY2022	rbot	Change In Value Shares ChangeInValueShares		shares
CY2022	rbot	Proceeds From Reverse Recapitalization Net Of Issuance Costs ProceedsFromReverseRecapitalizationNetOfIssuanceCosts		usd
CY2022	us-gaap	Proceeds From Issuance Of Warrants ProceedsFromIssuanceOfWarrants		usd
CY2021	rbot	Accruals For Property Plant And Equipment Purchased During The Period AccrualsForPropertyPlantAndEquipmentPurchasedDuringThePeriod		usd
CY2022	rbot	Warrants Assumed In Acquisition WarrantsAssumedInAcquisition		usd
CY2021	rbot	Effective Income Tax Rate Reconciliation Return To Provision EffectiveIncomeTaxRateReconciliationReturnToProvision		pure
CY2021	rbot	Effective Income Tax Rate Reconciliation Officers Compensation EffectiveIncomeTaxRateReconciliationOfficersCompensation		pure
CY2022	rbot	Effective Income Tax Rate Reconciliation Transaction Costs EffectiveIncomeTaxRateReconciliationTransactionCosts		pure
CY2021Q4	rbot	Deferred Tax Assets Tax Deferred Expense Capitalized Rd Expenses DeferredTaxAssetsTaxDeferredExpenseCapitalizedRDExpenses		usd
CY2022Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2021Q4	us-gaap	Deferred Tax Assets Net DeferredTaxAssetsNet		usd
CY2022	rbot	Share Based Compensation Arrangement By Shares Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementBySharesBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2021	rbot	Share Based Compensation Arrangement By Shares Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementBySharesBasedPaymentAwardFairValueAssumptionsExpectedDividendRate		pure
CY2022	dei	Amendment Flag AmendmentFlag	false
CY2022	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2022	dei	Entity Central Index Key EntityCentralIndexKey	0001812173

Files In Submission

Name	View Source	Status
0001213900-23-011661-index-headers.html	Edgar Link	pending
0001213900-23-011661-index.html	Edgar Link	pending
0001213900-23-011661.txt	Edgar Link	pending
0001213900-23-011661-xbrl.zip	Edgar Link	pending
f10k2022ex23-1_vicarious.htm	Edgar Link	pending
f10k2022ex31-1_vicarious.htm	Edgar Link	pending
f10k2022ex31-2_vicarious.htm	Edgar Link	pending
f10k2022ex32_vicarious.htm	Edgar Link	pending
f10k2022_vicarious.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image_001.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
f10k2022_vicarious_htm.xml	Edgar Link	completed
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
rbot-20221231.xsd	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
rbot-20221231_lab.xml	Edgar Link	unprocessable
rbot-20221231_def.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
rbot-20221231_cal.xml	Edgar Link	unprocessable
rbot-20221231_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$RBOT
Vicarious Surgical Inc. Stock $rbot

2022 Q4 Form 10-K Financial Statement

#000121390023011661 Filed on February 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RBOT Vicarious Surgical Inc. Stock $rbot

2022 Q4 Form 10-K Financial Statement

#000121390023011661 Filed on February 15, 2023

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$RBOT
Vicarious Surgical Inc. Stock $rbot